中国药物化学杂志2016,Vol.26Issue(1) :37-40,44.DOI:10.14142/j.cnki.cn21-1313/r.2016.01.007

依折麦布的合成工艺改进

Improved synthesis of ezetimibe

刘春池 罗昌群 郝晨洲 宋帅 赵冬梅 程卯生
中国药物化学杂志2016,Vol.26Issue(1) :37-40,44.DOI:10.14142/j.cnki.cn21-1313/r.2016.01.007

依折麦布的合成工艺改进

Improved synthesis of ezetimibe

刘春池 1罗昌群 1郝晨洲 1宋帅 1赵冬梅 1程卯生1
扫码查看

作者信息

  • 1. 沈阳药科大学基于靶点的药物设计与研究教育部重点实验室,辽宁沈阳110016
  • 折叠

摘要

目的 改进依折麦布的合成工艺.方法 以4-羟基苯甲醛为起始原料,经苄基保护、缩合得到中间体N-(4-氟苯基)4.苄氧基苯亚甲胺(4);以氟苯为起始原料,经傅克酰化、还原、酯化反应得到中间体6-(4-氟苯基)四氢-2H-吡喃-2-酮(9);中间体4与中间体9经环合、氧化、还原、脱保护、拆分共10步反应得到依折麦布.结果与结论 目标化合物依折麦布的结构经MS、1 H-NMR谱确证,反应总收率达6.2%(以4-羟基苯甲醛计),化学纯度大于99.5%.

Abstract

Ezetimibe is a cholesterol absorption inhibitor developed by Merck Corporation and ScheringPlough Corporation.In this paper,a new synthetic route for preparing ezetimibe was designed on the base of several references,synthesized from a convergent synthesis.Intermediate 4,N-(4-fluorophenyl)-4-benzyloxybenzimide,was obtained via benzyl protection,condensation reaction,using 4-hydroxybenzaldehyde as the starting material;Intermediate 9,6-(4-fluorophenyl) tetrahydro-2H-pyran-2-one,was obtained via FriedelCrafts alkylation,reduction,esterification,using fluorobenzene as the starting material.The final product was prepared via cyclization of intermediates 4 and 9,oxidation,reduction,deprotection,chiral separation,with an overall yield of 6.2%.The structure of the target compound was confirmed by MS and 1H-NMR.

关键词

依折麦布/胆固醇吸收抑制剂/工艺改进

Key words

ezetimibe/cholesterol absorption inhibitor/process improvement

引用本文复制引用

出版年

2016
中国药物化学杂志
沈阳药科大学,中国药学会

中国药物化学杂志

CSTPCDCSCD
影响因子:0.463
ISSN:1005-0108
被引量2
参考文献量10
段落导航相关论文